Delivery Order SPE2DB25D3020-SPE2DB25FWKFE
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,532.22 to AmerisourceBergen Drug Corp for Neomycin-Polymyxin-Gramicidin eye drops (10mL) on July 24, 2025, with an ultimate completion date of July 25, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement to support military and federal healthcare systems'...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp for the supply of Neomycin-Polymyxin-Hydrocortisone eye drops. The contract has a total ceiling value of $3,088.52 and an ultimate completion date of August 9, 2024. Amerisourcebergen, a major pharmaceutical distributor, provides a wide range of medical products and supplies to support various government agencies and healthcare programs, including...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,022.34 firm-fixed-price delivery order to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distributor, to provide 4565803453 NEOMYC-POLYM-DEXAMETH EYE DROP 5ML. This award is a part of DLA's larger indefinite delivery contract (IDC) valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for Amerisourcebergen to deliver a comprehensive range of medical commodities to support...
- The Defense Logistics Agency awarded a $101,240 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561504198, described as NEOMYC-POLYM-DEXAMETH EYE DROP 5ML. The firm fixed price order is being fulfilled under DLA's pharmaceutical supply chain contract vehicle. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with delivery of the requested eye drops to occur between July 14-17, 2023. No set aside designation or...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp on July 29, 2025, for supply of XDEMVY 0.25% Drop 10ML pharmaceutical product. This is an unset-aside, competitively awarded firm fixed price delivery order with an ultimate completion date of August 19, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under...
- The Defense Logistics Agency awarded a $73,050 delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561987801, described as Neomycin-Polymyxin B-Dexamethasone Ophthalmic Ointment 5mL. The order was placed under an indefinite-delivery/indefinite-quantity contract vehicle and will be fulfilled by Amerisourcebergen's corporate office in Conshohocken, Pennsylvania by August 31, 2023. As a key logistics and procurement agency of the Department of Defense, the DLA supports...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,126.44, is for the delivery of NEOMYC-POLYM-GRAMICID eye drops in 10 milliliter vials. The award has a completion date of January 7, 2025 and is a firm fixed-price contract. Amerisourcebergen holds a broader $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- The Defense Logistics Agency awarded a delivery order valued at $1,223.59 to AmerisourceBergen Drug Corp for XDEMVY 0.25% Drop 10ML, with an ultimate completion date of September 2, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and running through December 2026. The place of performance is listed as...
- The Defense Logistics Agency awarded a delivery order valued at $1,540.29 to AmerisourceBergen Drug Corp for MIEBO 100% Eye Drop 3ML on August 25, 2025, with an ultimate completion date of August 26, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a $260 firm fixed price delivery order to Amerisourcebergen Drug Corporation for pharmaceutical item 4561697231, described as Neomycin-Polymyxin-Dexamethasone eye ointment in 3.5 gram tubes. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania, spanning from August 3 to August 4, 2023. No additional details were provided regarding the original solicitation requirements or whether this delivery order falls under a broader...
- SPE2DB25D3020Indefinite Delivery Contract
- SPE2DB25D3020-SPE2DB25FWKFEDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Neomycin-Polymyxin-Dexamethasone eye drops (5 mL) with a ceiling value of $1,210.91 under a firm fixed-price contract. This delivery order, issued on August 25, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and extending through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was applied to this award, indicating it was competitively awarded. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's DLA prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling supply of a vast range of pharmaceutical products, medications, vaccines, and medical supplies to defense healthcare programs worldwide. This specific delivery order for ophthalmic medication falls within the broader portfolio of pharmaceutical commodities the contractor supplies through its established relationship with the Defense Health Agency and other federal healthcare systems. The contract type reflects AmerisourceBergen's capability to fulfill diverse federal medical supply needs through established delivery order mechanisms.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/25/25 |